Emily Littlejohn (@elittlejohndo) 's Twitter Profile
Emily Littlejohn

@elittlejohndo

Rheumatologist, Lupologist 🦋@ClevelandClinic Assistant Professor @CleClinicLCM

ID: 3103390601

calendar_today22-03-2015 02:30:04

348 Tweet

1,1K Followers

310 Following

Dr. John Cush (@rheumnow) 's Twitter Profile Photo

Systematic review of anti-Sm Abs (17 studies) shows Sm Abs to have 90% specificity for SLE. Although Smith Abs assoc w/ higher SLE activity, they are not predictive of lupus nephritis. Anti-Sm is more commone in Black patients buff.ly/4gbzNdl

Systematic review of anti-Sm Abs (17 studies) shows Sm Abs to have 90% specificity for SLE. Although Smith Abs assoc w/ higher SLE activity, they are not predictive of lupus nephritis. Anti-Sm is more commone in Black patients buff.ly/4gbzNdl
Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ It is amazing to get TWO positive Phase 3 trial results* for #lupus this week: ➡️ Dapirolizumab-pegol (UCB/Biogen) for #SLE ➡️ Obinutuzumab (Roche) for lupus #nephritis *NB: a successful phase 3 trial is different from approval. Typically a second P3 is required by regulators

✅ It is amazing to get TWO positive Phase 3 trial results* for #lupus this week:
➡️ Dapirolizumab-pegol (UCB/Biogen) for #SLE
➡️ Obinutuzumab (Roche) for lupus #nephritis
*NB: a successful phase 3 trial is different from approval. Typically a second P3 is required by regulators
Adam J Brown (@adamjbrownmd) 's Twitter Profile Photo

Second edition of Rheumatology Made Ridiculously Simple is out now! This edition we actually have a professional artist and are no longer relying on my own bad drawings! #meded #rheumatology

Second edition of Rheumatology Made Ridiculously Simple is out now! This edition we actually have a professional artist and are no longer relying on my own bad drawings! #meded #rheumatology
Leonard Calabrese (@lcalabresedo) 's Twitter Profile Photo

Join our LIVE GLOBAL TOWN HALL w Georg Schett & Max Konig - the latest data on the theory and practice of CAR-T Rx for #autoimmunity - registration FREE - 2 hrs & our news letter x 1 yr- Designed for the busy clinician!! Emily Littlejohn Adam J Brown ccfcme.org/Clinical25

Join our LIVE GLOBAL TOWN HALL w Georg Schett &amp; <a href="/MaxKonigMD/">Max Konig</a> -  the latest data on the theory and practice of CAR-T Rx for #autoimmunity - registration FREE - 2 hrs &amp; our news letter x 1 yr- Designed for the busy clinician!! <a href="/ELittlejohnDO/">Emily Littlejohn</a> <a href="/AdamJBrownMD/">Adam J Brown</a>  ccfcme.org/Clinical25
Healio Rheumatology (@healiorheum) 's Twitter Profile Photo

🗣️ “Every day that goes by we feel more comfortable using the word #remission in #lupus,” Dr. Emily Littlejohn Cleveland Clinic. See more from the #BusyClinician special series on CAR-T. ⬇️ bit.ly/4boqYea

Healio Rheumatology (@healiorheum) 's Twitter Profile Photo

🔍 Emily Littlejohn looked beyond measures of disease activity for the benefits CAR T-cell therapy can bring to patients with #lupus Here are the key takeaways from her talk at the recent #BusyClinician symposium 👇 healio.com/news/rheumatol…

TheDaoIndex (@kdao2011) 's Twitter Profile Photo

Dr M Petri touts the benefits of HCQ- she has caveats: get an OCT at 5 years, if in rare instances the pt develops heart failure, get an endomyocardial biopsy #CCRE25

Dr M Petri touts the benefits of HCQ- she has caveats: get an OCT at 5 years, if in rare instances the pt develops heart failure, get an endomyocardial biopsy #CCRE25
Laurent ARNAUD (@lupusreference) 's Twitter Profile Photo

✅ In-depth knowledge of the interpretation of #antinuclear antibody (#ANA) testing is KEY for the diagnosis of #autoimmune diseases such as #Lupus. Nice talk at #lupus2025 Lupus 2025 Toronto by May Choi about the use of ML to profile ANA images 👍

✅ In-depth knowledge of the interpretation of #antinuclear antibody (#ANA) testing is KEY for the diagnosis of #autoimmune diseases such as #Lupus. 
Nice talk at #lupus2025 <a href="/LupusCongress/">Lupus 2025</a> Toronto by May Choi about the use of ML to profile ANA images 👍
Dr. John Cush (@rheumnow) 's Twitter Profile Photo

IMPACT Study - Certolizumab Efficacy in APS Pregnancies A pilot trial assessed the safety and value of tumour necrosis factor α inhibitor treatment with certolizumab in patients with high-risk pregnancies with antiphospholipid syndrome (APS). Certolizumab (CZP) was shown to

IMPACT Study - Certolizumab Efficacy in APS Pregnancies 

A pilot trial assessed the safety and value of tumour necrosis factor α inhibitor treatment with certolizumab in patients with high-risk pregnancies with antiphospholipid syndrome (APS). Certolizumab (CZP) was shown to